Contamination of coagulation factor concentrates with human parvovirus B19 genotype 1 and 2

Thrombosis and Haemostasis

Volumn 92, Issue 4, 2004, Pages 838-845

  Schneider, Beate ^a   Becker, Maria ^a   Brackmann, Hans Hermann ^a   Eis Hübinger, Anna Maria ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Coagulation factor concentrates; Genotype 2; Human parvovirus

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE; BLOOD CLOTTING FACTOR CONCENTRATE; NUCLEIC ACID; VIRUS DNA;

ARTICLE; BLOOD ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SEQUENCE; GENOTYPE; NONHUMAN; NUCLEIC ACID AMPLIFICATION; NUCLEOTIDE SEQUENCE; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; VIRAL CONTAMINATION; VIRUS DETECTION; VIRUS INACTIVATION; VIRUS STRAIN;

BLOOD COAGULATION FACTORS; DNA, VIRAL; DRUG CONTAMINATION; GENOTYPE; HUMANS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; QUALITY CONTROL;

EID: 6344230136     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-04-0229     Document Type: Article

References (35)

1. Zakrzewska K, Azzi A, Patou G, et al. Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reaction. Br J Haematol 1992; 81: 407-12.
2. Lefrère JJ, Mariotti M, Thauvin M. B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentrates. Lancet 1994; 343: 211-2.
3. Saldanha J, Minor P. Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: implications for efficiency and consistency of removal of B19 DNA during manufacture. Br J Haematol 1996; 93: 714-9.
4. Eis-Hübinger AM, Sasowski U, Brackmann HH. Parvovirus B19 DNA contamination in coagulation factor VIII products. Thromb Haemost 1999; 81: 476-7.
5. Schmidt I, Blümel J, Seitz H, et al. Parvovirus B19 DNA in plasma pools and plasma derivatives. Vox Sang 2001; 81: 228-35.
6. Bartolomei Corsi O, Azzi A, Morfini M, et al. Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J Med Virol 1988; 25: 165-70.
7. Lyon DJ, Chapman CS, Martin C, et al. Symptomatic parvovirus B19 infection and heat-treated factor IX concentrate. Lancet 1989; 1: 1085.
8. Yee TT, Cohen BJ, Pasi KJ, et al. Transmission of symptomatic parvovirus B19 infection by clotting factor concentrate. Br J Haematol 1996; 93: 457-9.
9. Santagostino E, Mannucci PM, Gringeri A, et al. Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100°C heat after lyophilization. Transfusion 1997; 37: 517-22.
10. Azzi A, Morfini M, Mannucci PM. The transfusion-associated transmission of parvovirus B19. Transfus Med Rev 1999; 13: 194-204.
11. Hino M, Ishiko O, Honda KI, et al. Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery. Br J Haematol 2000; 108: 194-5.
12. Blümel J, Schmidt I, Effenberger W, et al. Parvovirus B19 transmission by heat-treated clotting factor concentrates. Transfusion 2002; 42: 1473-81.
13. Nguyen QT, Sifer C, Schneider V, et al. Detection of an erythrovirus sequence distinct from B19 in a child with acute anaemia. Lancet 1998; 352: 1524.
14. Hokynar K, Söderlund-Venermo M, Pesonen M, et al. A new parvovirus genotype persistent in human skin. Virology 2002; 302: 224-8.
15. Servant A, Laperche S, Lallemand F, et al. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 2002; 76: 9124-34.
16. Gallinella G, Venturoli S, Manaresi E, et al. B19 virus genome diversity: epidemiological and clinical correlations. J Clin Virol 2003; 28: 1-13.
17. Nguyen QT, Wong S, Heegaard ED, et al. Identification and characterization of a second novel human erythrovirus variant, A6. Virology 2002; 301: 374-80.
18. Schneider B, Reber U, Tolba R, et al. Prevalence of human parvovirus genotype 1 and genotype 2 DNA in livers and bone marrows of adults. Annual Meeting of GfV - Joint Meeting with SIV, March 17-20, Tübingen, Germany.
19. Eis-Hübinger AM, Sasowski U, Brackmann HH, et al. Parvovirus B19 DNA is frequently present in recombinant coagulation factor VIII products. Thromb Haemost 1996; 76: 1120.
20. Hemauer A, von Poblotzki A, Gigler A, et al. Sequence variability among different parvovirus B19 isolates. J Gen Virol 1996; 77: 1781-5.
21. Shade RO, Blundell MC, Cotmore SF, et al. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 1986; 58: 921-36.
22. Saldanha J, Lelie N, Yu MW, et al. Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques. Vox Sang 2002; 82: 24-31.
23. Wong S, Young NS, Brown KE. Prevalence of parvovirus B19 in liver tissue: no association with fulminant hepatitis or hepatitis-associated aplastic anemia. J Infect Dis 2003; 187: 1581-6.
24. Söderlund M, von Essen R, Haapasaari J, et al. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 1997; 349: 1063-5.
25. Cassinotti P, Burtonboy G, Fopp M, et al. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol 1997; 53: 229-32.
26. Eis-Hübinger AM, Reber U, Abdul-Nour T, et al. Evidence for persistence of parvovirus B19 DNA in livers of adults. J Med Virol 2001; 65: 395-401.
27. Musiani M, Zerbini M, Gentilomi G, et al. Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis 1995; 172: 1360-3.
28. Ozawa K, Kurtzman G, Young N. Replication of the B19 parvovirus in human bone marrow cell cultures. Science 1986; 233: 883-6.
29. Srivastava A, Lu L. Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow. J Virol 1988; 62: 3059-63.
30. Munshi NC, Zhou S, Woody MJ, et al. Successful replication of parvovirus B19 in the human megakaryocytic leukemia cell line MB-02. J Virol 1993; 67: 562-6.
31. Blümel J, Schmidt I, Willkommen H, et al. Inactivation of parvovirus B19 during pasteurization of human serum albumin. Transfusion 2002; 42: 1011-8.
32. Yunoki M, Tsujikawa M, Urayama T, et al. Heat sensitivity of human parvovirus B19. Vox Sang 2003; 84: 164-9.
33. Aubin JT, Defer C, Vidaud M, et al. Large-scale screening for human parvovirus B19 DNA by PCR: application to the quality control of plasma for fractionation. Vox Sang 2000; 78: 7-12.
34. Cohen BJ, Field AM, Gudnadottir S, et al. Blood donor screening for parvovirus B19. J Virol Methods 1990; 30: 233-8.
35. Brown KE, Young NS, Alving BM, et al. Parvovirus B19: implications for transfusion medicine. Summary of a workshop. Transfusion 2001; 41: 130-5.